APP and early-onset autosomal dominant Alzheimer disease: Although APP is best known and studied for its role as the source of the Amyloid-β (Aβ) peptide in the pathogenesis of Alzheimer’s disease, recent studies suggest that this upregulation of APP represents a neuroprotective response as a lack of APP impairs motor and cognitive outcomes, and enhances neuronal cell death [7].